Anatara Lifesciences is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Our lead product Detach™ is a natural product that will help address global concerns around the overuse of antibiotics in animals and their feed that is contributing to the rise of so-called “super bugs” that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies.
Latest news All news
Anatara Lifesciences is pleased to release its Notice of General Meeting and Proxy Form for shareholders.
Please click here for the ASX announcement.
Anatara Lifesciences CSO, Dr Tracey Mynott, will speak at the first session of the Science Business Inspiration Series next week.
SESSION 1 – THE WHOLE JOURNEY: FROM IDEA TO REALITY
For more information click here.